How big is the India Pharmaceutical Market?

The Indian pharmaceutical market is massive! It’s currently valued at $50 billion and is expected to reach $65 billion by 2024 and a whopping $130 billion by 2030 ¹. India is the third-largest pharmaceutical market globally in terms of volume, and it’s the largest provider of generic medicines, accounting for 20% of global supply by volume ¹.

India’s pharmaceutical industry is driven by several factors, including:

– Government Support: The government’s Production Linked Incentive (PLI) schemes aim to boost domestic manufacturing capacity, particularly for high-value products ¹.
– Strong Domestic Demand: India’s large population and growing healthcare needs drive demand for pharmaceuticals.
– Export-Oriented: India exports pharmaceuticals to over 200 countries, with the US, Africa, and the UK being key markets ¹.
– Low-Cost Manufacturing: India’s expertise in low-cost generic and patented drug manufacturing makes it an attractive destination for pharmaceutical companies.

The industry is also supported by various initiatives, such as the:

– Production Linked Incentive (PLI) Scheme: Encourages domestic manufacturing of critical bulk drugs and pharmaceuticals ¹.
– Pharmaceutical Technology Upgradation Assistance Scheme: Helps MSMEs upgrade their technology ¹.

Overall, India’s pharmaceutical market is poised for significant growth, driven by a combination of government support, domestic demand, and export opportunities.